Sean Hawkey

The trial of the VSV-EBOV vaccine was called Ebola ça Suffit — French for “Ebola that’s enough.” Researchers say it’s both effective and quick, with no new Ebola cases 6 days after vaccination. The findings were published in The Lancet medical journal on Friday.

Read more at NPR.org.